Facebook
X
LinkedIn
ForwardPulse: The Clot Thickens: Managing the Mysteries of Venous Thromboembolism (VTE) in Malignancy
There is no single standardized guideline for managing venous thromboembolism (VTE) in patients with cancer, as VTE risk varies significantly by cancer type. In this review, we will discuss the key risk factors as well as current strategies for VTE prophylaxis and treatment.
Target Audience
Pharmacist
Learning Objectives
a. Describe the criteria and classification of venous thromboembolism (VTE) risk within the cancer population
b. Discuss the prophylactic treatment of VTE within the oncology population
c. Discuss specific treatment of VTE
Additional Information
| Attachment | Size |
|---|---|
 Audience Disclosure slide_50.pptx | 460.62 KB |
 How to access credits - Code access.doc | 99.5 KB |
There is no single standardized guideline for managing venous thromboembolism (VTE) in patients with cancer, as VTE risk varies significantly by cancer type. In this review, we will discuss the key risk factors as well as current strategies for VTE prophylaxis and treatment.
Sophia Kue, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.